1
/
of
1
Elabscience
SKU:PKSH031523
Recombinant Human CD226/DNAM-1 Protein (His Tag)(Active)
Recombinant Human CD226/DNAM-1 Protein (His Tag)(Active)
Regular price
$732.00 USD
Regular price
Sale price
$732.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human CD226/DNAM-1 Protein (His Tag)(Active), a cutting-edge product meticulously engineered to revolutionize the field of molecular biology. This highly advanced protein, derived from human sources, showcases exceptional activity and is equipped with a His Tag for enhanced detection and purification capabilities.
The Recombinant Human CD226/DNAM-1 Protein (His Tag)(Active) is a result of rigorous scientific research and development, ensuring utmost quality and reliability. With its active nature, this protein exhibits remarkable functionality, making it an invaluable tool for various experimental applications, including but not limited to cell signaling studies, protein-protein interaction analysis, and immunotherapy research.
Crafted with utmost precision, this protein is designed to facilitate seamless detection and purification processes. The incorporation of the His Tag enables efficient and specific binding to nickel-chelating resins, simplifying purification procedures and ensuring high yields of pure protein. This feature not only saves valuable time but also guarantees the utmost accuracy and reproducibility of experimental results.
Furthermore, the Recombinant Human CD226/DNAM-1 Protein (His Tag)(Active) boasts exceptional stability, ensuring prolonged shelf life and consistent performance. Its robust nature allows for long-term storage without compromising its activity, making it an ideal choice for laboratories and research institutions seeking reliable and long-lasting reagents.
In summary, the Recombinant Human CD226/DNAM-1 Protein (His Tag)(Active) represents a breakthrough in the realm of molecular biology. Its active nature, coupled with the His Tag for enhanced detection and purification, makes it an indispensable asset for researchers and scientists alike. With its exceptional stability and reliability, this protein is poised to revolutionize experimental studies and contribute to advancements in various fields, including cell signaling, protein-protein interactions, and immunotherapy research.
The Recombinant Human CD226/DNAM-1 Protein (His Tag)(Active) is a result of rigorous scientific research and development, ensuring utmost quality and reliability. With its active nature, this protein exhibits remarkable functionality, making it an invaluable tool for various experimental applications, including but not limited to cell signaling studies, protein-protein interaction analysis, and immunotherapy research.
Crafted with utmost precision, this protein is designed to facilitate seamless detection and purification processes. The incorporation of the His Tag enables efficient and specific binding to nickel-chelating resins, simplifying purification procedures and ensuring high yields of pure protein. This feature not only saves valuable time but also guarantees the utmost accuracy and reproducibility of experimental results.
Furthermore, the Recombinant Human CD226/DNAM-1 Protein (His Tag)(Active) boasts exceptional stability, ensuring prolonged shelf life and consistent performance. Its robust nature allows for long-term storage without compromising its activity, making it an ideal choice for laboratories and research institutions seeking reliable and long-lasting reagents.
In summary, the Recombinant Human CD226/DNAM-1 Protein (His Tag)(Active) represents a breakthrough in the realm of molecular biology. Its active nature, coupled with the His Tag for enhanced detection and purification, makes it an indispensable asset for researchers and scientists alike. With its exceptional stability and reliability, this protein is poised to revolutionize experimental studies and contribute to advancements in various fields, including cell signaling, protein-protein interactions, and immunotherapy research.
Share
